tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Arcutis Biotherapeutics (ARQT) Income Statement

Compare
770 Followers

Arcutis Biotherapeutics Income Statement

Last quarter (Q3 2024), Arcutis Biotherapeutics's total revenue was $44.76M, an increase of 17.44% from the same quarter last year. In Q3, Arcutis Biotherapeutics's net income was $-41.54M. See Arcutis Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 59.61M$ 3.69M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 54.62M$ 2.93M$ -763.00K$ -455.00K$ -195.00K
Operating Expenses
$ 295.72M$ 304.56M$ 206.53M$ 136.65M$ 43.13M
Depreciation and Amortization
$ 1.88M$ 1.25M$ 763.00K$ 455.00K$ 195.00K
EBITDA
$ -227.43M$ -294.55M$ -205.59M$ -135.22M$ -41.80M
Operating Income
$ -241.10M$ -301.63M$ -206.53M$ -136.65M$ -43.13M
Other Income/Expenses
$ -17.93M$ -9.83M$ 173.00K$ 967.00K$ 1.14M
Pretax Income
$ -259.03M$ -311.46M$ -206.36M$ -135.68M$ -42.00M
Net Income
$ -262.14M$ -321.29M$ -205.90M$ -135.68M$ -42.00M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.78$ -5.84$ -4.17$ -3.80$ -1.10
Diluted EPS
$ -3.78$ -5.84$ -4.17$ -3.80$ -1.10
Weighted Average Shares Outstanding
69.31M 55.03M 49.41M 35.67M 38.09M
Weighted Average Shares Outstanding (Diluted)
69.31M 55.03M 49.41M 35.67M 38.09M
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis